急性早幼粒细胞白血病患者早期死亡率:系统评价与Meta分析
本系统评价与Meta分析纳入140项研究、54,923例新诊断急性早幼粒细胞白血病患者,旨在评估早期死亡率(诊断后30天内死亡)。122项研究的Meta分析早期死亡率为12%,介入性研究为8%,观察性研究为15%。早期死亡主要原因为出血(57%),其次为脓毒症(18%)、分化综合征(12%)和血栓事件(2%)。Meta回归显示早期死亡率受患者年龄、诊断时白细胞计数、时间、研究类型和根据收入分类的原籍国影响。作者认为早期死亡率随时间呈令人鼓舞的下降,但介入性研究结果向真实世界实践转化存在困难,提出需要改进和标准化早期管理,尤其是在重症监护病房。
要点
- 122项研究的Meta分析显示急性早幼粒细胞白血病早期死亡率为12%。
- 介入性研究早期死亡率为8%,低于观察性研究的15%。
- 出血是早期死亡的主要原因(57%),其次为脓毒症(18%)、分化综合征(12%)和血栓事件(2%)。
- Meta回归显示早期死亡率受患者年龄、诊断时白细胞计数、时间、研究类型和根据收入分类的原籍国影响。
- 作者认为需要改进和标准化早期管理,尤其是在重症监护病房。
适用人群与场景
- 新诊断的急性早幼粒细胞白血病患者。
- 纳入所有关注早期死亡率的研究。
- 早期死亡率定义为诊断后30天内死亡。
研究设计与关键结果
- 研究类型为系统评价与Meta分析,纳入140项研究,共54,923例新诊断急性早幼粒细胞白血病患者。
- 122项研究的Meta分析早期死亡率为12%。
- 介入性研究早期死亡率为8%,观察性研究为15%。
- 早期死亡原因:出血57%,脓毒症18%,分化综合征12%,血栓事件2%。
- Meta回归显示早期死亡率受患者年龄、诊断时白细胞计数、时间、研究类型和根据收入分类的原籍国影响。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析。
- 采用随机效应模型进行Meta分析。
- 使用Cochrane偏倚风险2量表评估随机对照试验,使用纽卡斯尔-渥太华量表评估其他类型研究。
对床旁实践的改变
- 作者认为需要改进和标准化早期管理,尤其是在重症监护病房。
- 早期死亡率在介入性研究中低于观察性研究,作者认为这反映了随机对照试验和介入性研究的成功向真实世界临床实践转化的困难。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: In patients with acute promyelocytic leukemia (APL), early mortality, defined as death within 30 days following diagnosis, is the main driver of overall survival. Intensivists play a pivotal role in the management of patients with APL.
METHOD: The PubMed and Embase databases were searched on December 1, 2023. All studies focusing on early mortality in patients with newly diagnosed APL were included. Two reviewers independently selected the studies and assessed bias using the risk-of-bias 2 scale for randomized controlled trials (RCT) and the Newcastle-Ottawa scale for other types of studies. A meta-analysis using a random effects model was performed. The primary outcome was early mortality. A subgroup analysis was performed to assess the differences between interventional and observational studies. Secondary outcomes included reasons for early mortality and the occurrence of severe hemorrhage or differentiation syndrome (DS).
RESULTS: Of the 950 studies screened, 140 met the inclusion criteria. A total of 54,923 patients newly diagnosed with APL were included in the meta-analysis. A meta-analytical early mortality rate of 12% was calculated across 122 studies. Early mortality was lower in interventional studies (8%) than in observational studies (15%). Hemorrhage was the main cause of early mortality (57%), followed by sepsis (18%), DS (12%), and thrombotic events (2%). In a meta-regression, early mortality was influenced by patients' age, white blood cell count at diagnosis, time, study type, and country of origin according to income classification.
CONCLUSION: There is an encouraging decrease over time of early mortality in patients with APL. Early mortality is lower in interventional studies. This result reflects the difficulty of translating the successes of RCT and interventional research into real-world clinical practice. This study puts forward the need to improve and standardize early management, notably in the intensive care unit.
TRIAL REGISTRATION: This study's protocol was preregistered on PROSPERO (CRD42023488480).
参考来源
- Chean D, Kemp H, Fodil S, et al. Early mortality in patients with acute promyelocytic leukemia: a systematic review and meta-analysis. Crit Care. 2025. PMID: 41239429. doi:10.1186/s13054-025-05743-7
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。